Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)
Clinical trial NCT04080245 · COMPLETED
Trial details
- NCT number
- NCT04080245
- Sponsor
- University of Alabama at Birmingham
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-15
- Primary completion
- 2025-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.